139 related articles for article (PubMed ID: 25399887)
1. Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction.
Jiao Q; Ke Q; Li W; Jin M; Luo Y; Zhang L; Yang D; Zhang X
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):162-70. PubMed ID: 25399887
[TBL] [Abstract][Full Text] [Related]
2. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
Zhao XJ; Liu XL; He GX; Xu HP
Braz J Med Biol Res; 2014 Feb; 47(3):245-51. PubMed ID: 24554037
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
[TBL] [Abstract][Full Text] [Related]
4. Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade.
Hernández-Reséndiz S; Palma-Flores C; De Los Santos S; Román-Anguiano NG; Flores M; de la Peña A; Flores PL; Fernández-G JM; Coral-Vázquez RM; Zazueta C
Basic Res Cardiol; 2015 Mar; 110(2):1. PubMed ID: 25589055
[TBL] [Abstract][Full Text] [Related]
5. The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion.
Shao L; Wu D; Zhang P; Li W; Wang J; Su G; Liao Y; Wang Z; Liu K
Clin Appl Thromb Hemost; 2013; 19(1):19-28. PubMed ID: 22387586
[TBL] [Abstract][Full Text] [Related]
6. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
7. The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: the role of inflammation.
Celik T; Iyisoy A; Yuksel UC; Jata B; Ozkan M
Int J Cardiol; 2009 Jul; 136(1):86-8; author reply 88-9. PubMed ID: 18579226
[TBL] [Abstract][Full Text] [Related]
8. Sodium tanshinone IIA sulfonate ameliorates experimental coronary no-reflow phenomenon through down-regulation of FGL2.
Long R; You Y; Li W; Jin N; Huang S; Li T; Liu K; Wang Z
Life Sci; 2015 Dec; 142():8-18. PubMed ID: 26482204
[TBL] [Abstract][Full Text] [Related]
9. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
[TBL] [Abstract][Full Text] [Related]
10. Pivotal role of protein kinase Cdelta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation.
Wong SL; Lau CW; Wong WT; Xu A; Au CL; Ng CF; Ng SS; Gollasch M; Yao X; Huang Y
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1169-76. PubMed ID: 21311042
[TBL] [Abstract][Full Text] [Related]
11. No-reflow phenomenon: maintaining vascular integrity.
Kloner RA
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
[TBL] [Abstract][Full Text] [Related]
12. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
[TBL] [Abstract][Full Text] [Related]
13. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells.
Kibayashi E; Urakaze M; Kobashi C; Kishida M; Takata M; Sato A; Yamazaki K; Kobayashi M
Clin Sci (Lond); 2005 Jun; 108(6):515-21. PubMed ID: 15701058
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of admission N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction].
Wang ZY; Liu N; Lei LC; Ren LH; Ye HM; Peng JJ
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3403-6. PubMed ID: 23327699
[TBL] [Abstract][Full Text] [Related]
16. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
Xu P; Qi XY; Li CH; Zhang JH; Liu DM; Liu J; Wang WL
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Hu T; Wang HC; Wang RT; Lv AL; Luan RH; Li CX; Cheng HX; Xia CH; Tao L
Cardiovasc Ther; 2013 Jun; 31(3):e7-e11. PubMed ID: 22953997
[TBL] [Abstract][Full Text] [Related]
18. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
[TBL] [Abstract][Full Text] [Related]
19. Osthole ameliorates acute myocardial infarction in rats by decreasing the expression of inflammatory-related cytokines, diminishing MMP-2 expression and activating p-ERK.
Duan J; Yang Y; Liu H; Dou PC; Tan SY
Int J Mol Med; 2016 Jan; 37(1):207-16. PubMed ID: 26549213
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
